ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,245.37
-0.48%
Dow Jones
38,798.99
-0.22%
Gold vs US Dollar
2,295.79
-0.11%
Brent Oil
79.765
0.53%
Bitcoin
69,600.50
-0.08%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Intesity Therapeutics Inc (INTS) Share Price

INTS Intesity Therapeutics Inc

4.86
-0.1194 (-2.40%)
07 Jun 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Intesity Therapeutics Inc NASDAQ:INTS NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.1194 -2.40 4.86 4.68 5.07 4.9999 4.77 4.98 6,682 21:51:37   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Biological Pds,ex Diagnstics  -11.86M -0.8652 -5.52 65.53M
 Type  Size  Price  Time  Units 
 9 1 5.00 21:39:35 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore INTS News
07/06/202422:29EDGAR2Form SC 13G - Statement of acquisition of beneficial ownership by individuals
07/06/202412:26EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
04/06/202421:07EDGAR2Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
04/06/202421:05EDGAR2Form DEF 14A - Other definitive proxy statements
04/06/202421:02EDGAR2Form ARS - Annual Report to Security Holders
24/05/202421:00EDGAR2Form 8-K - Current report
15/05/202413:01PRNUSIntensity Therapeutics, Inc. Announces the Appointment of Thomas Dubin to Its Board of Directors
Period
Draw mode
Data Downloads for INTS

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Intesity Therapeutics Inc Articles